1990至2020年欧洲卵巢癌死亡率趋势及2025年预测
该研究分析31个欧洲国家1990-2020年卵巢癌死亡率数据并预测2025年趋势。大多数国家死亡率呈有利下降趋势,EU-27从2010-2014年到2015-2019年下降5.9%至ASMR 4.66/10万,预计到2025年降至4.17/10万。
要点
- EU-27卵巢癌死亡率从2010-2014年到2015-2019年下降5.9%,ASMR达4.66/10万。
- 同期EU-14国家死亡率下降7.0%,转型国家下降2.1%。
- 预测至2025年EU-27卵巢癌ASMR降至4.17/10万。
核心结论
- 欧洲卵巢癌死亡率预计将持续有利下降趋势,主要归因于后续世代欧洲女性口服避孕药使用增加,绝经激素替代治疗使用减少及诊断和管理改善也可能发挥作用。
研究设计与样本
- 从世界卫生组织数据库提取31个欧洲国家1990-2020年女性卵巢癌人口和死亡证明数据,基于世界标准人口计算每10万女性年的年龄标准化死亡率(ASMR),使用joinpoint回归模型预测2025年并计算1994-2025年避免死亡数。
主要发现
- 观察期内大多数国家卵巢癌死亡率呈有利模式。
- EU-27从2010-2014年到2015-2019年死亡率下降5.9%,ASMR达4.66/10万。
- 同期EU-14国家死亡率下降7.0%,转型国家下降2.1%。
- 英国死亡率也下降,ASMR达5.29。
- 预测至2025年EU-27卵巢癌死亡率降至4.17/10万。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Over the last decades, ovarian cancer mortality in Europe has been decreasing, but disparities in trends were observed. In this paper, we analysed ovarian cancer mortality trends in Europe over the period 1990-2020 and predicted the number of deaths and rates by 2025. METHODS: We extracted population and death certification data from ovarian cancer in women for 31 European countries, between 1990 and 2020 from the World Health Organization database. We computed age-standardised mortality rates (ASMR) per 100,000 women-years, based on the world standard population. We also obtained predictions for 2025 using a joinpoint regression model and calculated the number of avoided deaths over the period 1994-2025. RESULTS: Over the observed period, mortality from ovarian cancer showed a favourable pattern in most countries. In the EU-27, rates declined by 5.9% from 2010-2014 to 2015-2019, reaching an ASMR of 4.66/100,000. During the same period, the decline in ovarian cancer mortality was more pronounced in the EU-14 countries (-7.0%) compared to Transitional countries (-2.1%). Declines were also observed in the United Kingdom, to reach an ASMR of 5.29. Decreases in mortality from ovarian cancer are predicted until 2025, to 4.17/100,000 for the EU-27. CONCLUSIONS: Favourable trends in ovarian cancer mortality are expected to persist in Europe and can be mainly attributed to the increased use of oral contraceptives in subsequent generations of European women. Decreased use of menopausal Hormone Replacement Therapy and improved diagnosis and management may also have played a role.
引用
- Wojtyła C, Bertuccio P, Giermaziak W, et al. European trends in ovarian cancer mortality, 1990-2020 and predictions to 2025. Eur J Cancer. 2023. PMID: 37837925. doi:10.1016/j.ejca.2023.113350
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。